The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program. Dr.

The FDA recently unveiled a new national priority voucher program that would seek to trade faster drug approvals for lower ...

It is unclear how the Trump administration will consider affordability when reviewing a drug, as prices are usually determined after an approval in the U.S.

Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is getting better, and use is not mandatory.

The FDA will select at most five companies that align with national priorities, including lower drug prices and increased ...

Food and Drug Administration Commissioner Marty Makary said the agency will aim to review select drugs in one to two months. FDA's long-standing accelerated approval program generally issues ...

George Tidmarsh, a Stanford University physician who founded Horizon Pharma and later ran La Jolla Pharma, was named head of ...

Food and Drug Administration Commissioner Marty Makary said the agency will aim to review select drugs in one to two months. FDA's long-standing accelerated approval program generally issues ...

Food and Drug Administration Commissioner Marty Makary said the agency will aim to review select drugs in one to two months. FDA's long-standing accelerated approval program generally issues ...

The Food and Drug Administration (FDA) is persistently underresourced and lacks certain authorities to oversee the Human Foods Program, as recently documented in a report issued by the Reagan ...